Spotlight
Specialty
Partners
CME/CE
Precision Medicine: A Collaborative and Multidisciplinary Approach to Identifying Biomarkers : Episode 12
Future Directions in Precision Medicine: An Evolving Treatment Landscape
Closing out their discussion on biomarkers and precision medicine in cancer care, key opinion leaders look toward future evolutions in the oncology landscape.
EP: 1.Targetable Mutations and Rearrangements in Lung Cancers
EP: 2.Targetable Mutations Found in Breast Cancers
EP: 3.Addressing Barriers to Adequate Biomarker Testing in Cancer Care
EP: 4.Optimizing Cancer Care: Interpreting and Communicating Biomarker Testing Results
EP: 5.Armamentarium of Biomarker Testing Strategies in Cancer Care
EP: 6.Updating Biomarker Testing Strategies as Cancer Care Evolves
EP: 7.Optimizing the Timing and Utilization of Biomarker Testing in Cancer Care
EP: 8.Improving Uptake of Biomarker Testing and Precision Medicine in Cancer Care
EP: 9.The Value of Molecular Tumor Boards and Multidisciplinary Care
EP: 10.Role of a Pharmacist in the Multidisciplinary Approach to Identifying Biomarkers
EP: 11.Role of a Pharmacist in Developing Treatment Pathways and Educating Patients
Now Viewing
EP: 12.Future Directions in Precision Medicine: An Evolving Treatment Landscape
Related Videos
Related Content
